A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease

被引:14
|
作者
Jerkins, Gary [1 ]
Greiner, Jack, V [2 ,3 ]
Tong, Louis [4 ,5 ,6 ]
Tan, Jacqueline [7 ]
Tauber, Joseph [8 ]
Mearza, Ali [9 ,10 ]
Srinivasan, Sruthi [11 ]
机构
[1] Adv Vis Res LLC, Nashville, TN 37205 USA
[2] Clin & & Res Boston, Boston, MA USA
[3] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[4] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore, Singapore
[5] Singapore Eye Res Inst, Singapore, Singapore
[6] Duke Natl Univ, Singapore Med Sch, Singapore, Singapore
[7] Univ New South Wales, Sydney, NSW, Australia
[8] Tauber Eye Ctr, Kansas City, MO USA
[9] Imperial Coll Healthcare NHS Trust, London, England
[10] Ophthalm Consultants London, London, England
[11] Alcon Res LLC, Johns Creek, GA USA
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
dry eye; lipid-deficient; evaporative dry eye; lubricant eye drops; non-inferiority; ARTIFICIAL TEARS; MULTICENTER; DEFICIENT; EMULSION; LAYER;
D O I
10.2147/OPTH.S256351
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to compare the efficacy of two lipid-based lubricant eye drops in patients with lipid-deficient dry eye. Methods: This Phase IV, multicenter, prospective, double-masked study enrolled adults (aged >= 18 years) who had a tear film breakup time (TFBUT) of <= 15 seconds(s), and unanesthetized Schirmer I test of >= 3 mm to <= 12 mm in at least one eye, at both screening and baseline visits. Eligible patients (n=231) were randomized (1:1) and received either Systane (R) Balance (SYSB; n=117) or Refresh (R) Optive Advanced (RFO-Ad, n=114), four-times a day, for 35 days. The primary endpoint was non-inferiority for change from baseline in TFBUT at Day 35 (noninferiority was established if the lower limit of the 95% confidence interval (CI) for the difference between the treatment groups was > -1.0 s); secondary endpoints (test of superiority) were change in TFBUTand global ocular discomfort visual analog scale (VAS) score at Day 35. Other endpoints included the impact of dry eye on everyday life (IDEEL) treatment satisfaction scores (inconvenience and effectiveness) and safety. Results: At Day 35, themean change from baseline in TFBUTwas 0.998 s in the SYSB and 0.868 s in the RFO-Ad groups with a treatment difference: 0.130 s; (95% CI -0.34, 0.60; P<0.0001) demonstrating non-inferiority of SYSB to RFO-Ad. The global ocular discomfort VAS scores improved in both groups, with a mean change from baseline of -9.7 and -8.8 in SYSB and RFOAd groups (treatment difference -0.8; P=0.62), respectively. No meaningful difference was observed in IDEEL treatment effectiveness and treatment inconvenience scores between SYSB vs RFO-Ad (P>0.05 for treatment difference). Both treatments were well tolerated. Conclusion: SYSB lubricant eye drops were non-inferior to RFO-Ad for improvement in TFBUT in patients with lipid-deficient dry eye. Both lubricant eye drops improved TFBUT and ocular discomfort scores in patients with lipid-deficient dry eye.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 50 条
  • [41] Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal Trials
    Shen Lee, Bridgitte
    Toyos, Melissa
    Karpecki, Paul
    Schiffbauer, Jessica
    Sheppard, John
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (04) : 1333 - 1369
  • [42] Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial
    Baiza-Duran, Leopoldo M.
    Munoz-Villegas, Patricia
    Sanchez-Rios, Alejandra
    Olvera-Montano, Oscar
    JOURNAL OF OPHTHALMOLOGY, 2023, 2023
  • [43] Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits
    Eldesouky, Lubna M.
    El-Moslemany, Riham M.
    Ramadan, Alyaa A.
    Morsi, Mahmoud H.
    Khalafallah, Nawal M.
    PHARMACEUTICS, 2021, 13 (03)
  • [44] Efficacy and Safety of Quantum Molecular Resonance Electrotherapy in Patients with Aqueous-Deficient, Evaporative and Mixed-Type Dry Eye: A Randomized Interventional Study
    Antonio Ballesteros-Sánchez
    José-María Sánchez-González
    Giovanni Roberto Tedesco
    Carlos Rocha-De-Lossada
    Fedele Russo
    Antonio Spinelli
    Irene Ingrande
    Davide Borroni
    Ophthalmology and Therapy, 2024, 13 : 495 - 507
  • [45] Efficacy and Safety of Quantum Molecular Resonance Electrotherapy in Patients with Aqueous-Deficient, Evaporative and Mixed-Type Dry Eye: A Randomized Interventional Study
    Ballesteros-Sanchez, Antonio
    Sanchez-Gonzalez, Jose-Maria
    Tedesco, Giovanni Roberto
    Rocha-De-Lossada, Carlos
    Russo, Fedele
    Spinelli, Antonio
    Ingrande, Irene
    Borroni, Davide
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 21 - 50
  • [46] A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
    Wirta, David L.
    Torkildsen, Gail L.
    Moreira, Helen R.
    Lonsdale, John D.
    Ciolino, Joseph B.
    Jentsch, Garrit
    Beckert, Michael
    Ousler, George W.
    Steven, Philipp
    Kroesser, Sonja
    OPHTHALMOLOGY, 2019, 126 (06) : 792 - 800
  • [47] Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial
    Laihia, Jarmo
    Jarvinen, Riikka
    Wylegala, Edward
    Kaarniranta, Kai
    ACTA OPHTHALMOLOGICA, 2020, 98 (03) : 244 - 254
  • [48] Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
    Liu, Shuang
    Yang, Guang
    Li, Qingnan
    Tang, Shaohua
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (04) : 1304 - +
  • [49] Evaluation of the Safety and Efficacy of Intense Pulsed Light Treatment with Meibomian Gland Expression of the Upper Eyelids for Dry Eye Disease
    Toyos, Rolando
    Toyos, Melissa
    Willcox, Jennifer
    Mulliniks, Haylie
    Hoover, James
    PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY, 2019, 37 (09) : 527 - 531
  • [50] Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery
    Fogagnolo, Paolo
    Romano, Dario
    De Ruvo, Valentino
    Sabella, Pierfilippo
    Rossetti, Luca
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 38 (04) : 305 - 310